comparemela.com

Page 5 - Biosystems Taqpath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State

Spiking variants Understanding the impact of emerging SARS-CoV-2 variants is essential to inform the development of effective antiviral measures. Studies have indicated that the D614G substitution in the SARS-CoV-2 Spike protein may increase transmissibility, but to what extent this variant has propelled the pandemic is debated. Analyzing thousands of viral genomes together with clinical data, Müller et al. found no evidence that the 614G variant rose in frequency in Washington State mid-2020 due to increased transmissibility or virulence. Instead, the data provided a stronger signal that the surge in 614G was explainable by its repeated introduction into the state as well as local differences in lockdown measures both human-catalyzed factors.

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.

MAKO Medical Forges Partnership with the CDC

MAKO Medical Forges Partnership with the CDC North Carolina lab to provide nationwide next-generation sequencing of COVID-19 samples for identification of mutations and variants May 13, 2021 13:58 ET | Source: MAKO Medical MAKO Medical Raleigh, North Carolina, UNITED STATES Raleigh, North Carolina, May 13, 2021 (GLOBE NEWSWIRE) MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced a comprehensive partnership with the Centers for Disease Control and Prevention (CDC) to provide next-generation sequencing of SARS-CoV-2. Since January 2021, MAKO has utilized sequencing processes to analyze a group of more than 2,500 samples from tests conducted across its forty-three state testing footprint. To date, these efforts have identified the occurrence of multiple variants of the SARS-CoV-2 virus, including the B.1.1.7, B.1.351, and B.1.429 variants, across 25 states.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.